Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BCAX

Bicara Therapeutics Inc

May 29 • 04:00PM ET

21.75

0.00 0.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: IDYA CGON RCUS TNGX KYMR NUVL BMRN RYTM INCY KRYS

| Held by: VTI XBI IWM VXF IBB IWN VTWO SCHA FESM DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.77	Insider Own	33.47%	Shs Outstand	65.55M	Perf Week	4.37%
Market Cap	1.43B	Forward P/E	-	EPS next Y	-3.70	Insider Trans	0.24%	Shs Float	37.56M	Perf Month	2.21%
Enterprise Value	890.75M	PEG	-	EPS next Q	-0.80	Inst Own	77.96%	Short Float	26.22%	Perf Quarter	29.62%
Income	-157.31M	P/S	-	EPS this Y	-35.40%	Inst Trans	15.81%	Short Ratio	17.66	Perf Half Y	17.82%
Sales	0.00M	P/B	2.77	EPS next Y	-8.49%	ROA	-30.50%	Short Interest	9.85M	Perf YTD	29.23%
Book/sh	7.84	P/C	2.65	EPS next 5Y	-11.94%	ROE	-32.34%	52W High	24.25 -10.31%	Perf Year	130.40%
Cash/sh	8.21	P/FCF	-	EPS past 3/5Y	-53.65% -	ROIC	-30.59%	52W Low	8.48 156.49%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.15% 5.50%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-63.41%	Oper. Margin	-	ATR (14)	1.11	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	13.85	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	51.96	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	13.85	EPS Q/Q	-36.83%	SMA20	0.35%	Beta	-0.53	Target Price	31.46
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	1.57%	Rel Volume	0.62	Prev Close	21.75
Employees	103	LT Debt/Eq	0.00	Earnings	May 11 BMO	SMA200	26.31%	Avg Volume	557.65K	Price	21.75
IPO	Sep 13, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	-43.23% -	Trades		Volume	348,521	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)